Verve Therapeutics, Inc. (VERV)
Delisted
25 Jul 2025
NASDAQ (NGS) NASDAQ (NGS) Primary $
11. 13
+0.03
+0.27%
$
994.04M Market Cap
- P/E Ratio
- Div Yield
10,306,656 Volume
-2.93 Eps
$ 11.1
Previous Close Investors:
Day Range
11.13 11.13
Year Range
2.865 11.4
Want to track VERV and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
